Researchers at the McGovern Institute for Brain Research at MIT and the Broad Institute of MIT and Harvard have harnessed a natural bacterial system to develop a new protein delivery approach that works in human cells and animals. The technology, described today in Nature, can be programmed to deliver a variety of proteins, including ones for gene editing, to different cell types. The system could potentially be a safe and efficient way to deliver gene therapies and cancer therapies. Led by MIT Associate Professor Feng Zhang, who is a McGovern…
